Our community narratives are driven by numbers and valuation.
Jamjoom Pharmaceuticals is betting on rising healthcare demand across the Middle East and North Africa, helped by Saudi healthcare spending and a push into new types of medicines beyond its traditional strengths. But its growth may come with trade-offs, like heavier exposure to lower-profit sales channels, reliance on partners for new products, and regional and supply constraints that could squeeze results.Read more
